Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LOD-RISK study)

Blood Pressure Monitoring

Volumn 14, Issue 4, 2009, Pages 145-151

  García Ortiz, Luis ^a,b,c   Gómez Marcos, Manuel A ^a   Martín Moreiras, Javier ^a   González Elena, Luis J ^a   Recio Rodriguez, Jose I ^a   Castaño Sánchez, Yolanda ^a   Grandes, Gonzalo ^b   Martínez Salgado, Carlos ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b Primary Care Research Unit of Bizkaia   (Spain)

^c Biomedical Research Institute of Salamanca IBSAL   (Spain)

Author keywords

Ambulatory; Blood pressure monitoring; Carotid artery injuries; Hypertension; Kidney disease; Left ventricular hypertrophy

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANAMNESIS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MONITORING; CAROTID ARTERY INJURY; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS;

EID: 68949105465     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBP.0b013e32832e062f     Document Type: Article

References (25)

1. Terpstra WF, May JF, Smit AJ, De Graeff PA, Crijns HJ. Microalbuminuria is related to marked end organ damage in previously untreated, elderly hypertensive patients. Blood Press 2002; 11:84-90.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. W Engl J Med 2004; 351:1296-1305.
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
4. Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni C, Pearson TA, Ambrosio G. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 2001; 104:2039-2044.
5. Dijk JM, Van der Graaf Y, Bots ML, Grobbee DE, Algra A. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study. Eur Heart J 2006; 27:1971-1978.
6. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46:156-161.
7. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005; 19:801-807.
8. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783.
9. Kikuya M, OhkuboT, Asayama K, Metoki H, ObaraT, Saito S, etal. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45:240-245.
10. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure and mortality: a population-based study. Hypertension 2005; 45:499-504.
11. Verdecchia P, Borgioni C, Ciucci A, Gattobigio R, Schillaci G, Sacchi N, et al. Prognostic significance of blood pressure variability in essential hypertension. Blood Press Monit 1996; 1:3-11. (Pubitemid 126441344)
12. Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007; 50:325-332.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
14. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
15. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23:697-701.
16. O'Brien EPJ, Littler W, De Swiet M, Padfield PL, Altman DG, Bland M, et al. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11 (Suppl 2): S43-S63.
17. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23:75-80.
18. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995; 25:417-423.
19. Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev 2007; 59:923-939. (Pubitemid 47531897)
20. Cuspidi C, Valerio C, Sala C, Esposito A, Masaidi M, Negri F, et al. Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure. Blood Press Monit 2008; 13:7-13.
21. Muxfeldt ES, Salles GF. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension? J Hypertens 2008; 26:878-884.
22. Barrios V, Escobar C, Bertomeu V, Murga N, De Pablo C, Asin E. High heart rate: more than a risk factor. Lessons from a clinical practice survey. Int J Cardiol 2008. doi: 10.1016/j.ijcard.2008.05.045.
23. Hall AS, Palmer S. The heart rate hypothesis: ready to be tested. Heart 2008; 94:561-565.
24. Bangalore S, Sawhney S, Messerli FH. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 2008; 52:1482-1489.
25. Cuspidi C, Valerio C, Meani S, Sala C, Esposito A, Masaidi M, et al. Ambulatory heart rate and target organ damage in never-treated essential hypertensives. J Hum Hypertens 2008; 2289-2295.